Chaim Indig
Net Worth
Last updated:
What is Chaim Indig net worth?
The estimated net worth of Mr. Chaim Indig is at least $64,445,965 as of 15 Oct 2024. He owns shares worth $34,104,877 as insider, has earned $24,908,808 from insider trading and has received compensation worth at least $5,432,280 in Phreesia, Inc..
What is the salary of Chaim Indig?
Mr. Chaim Indig salary is $905,380 per year as Co-Founder, Chief Executive Officer & Director in Phreesia, Inc..
How old is Chaim Indig?
Mr. Chaim Indig is 46 years old, born in 1979.
What stocks does Chaim Indig currently own?
As insider, Mr. Chaim Indig owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Phreesia, Inc. (PHR) | Co-Founder, Chief Executive Officer & Director | 1,220,647 | $27.94 | $34,104,877 |
What does Phreesia, Inc. do?
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Chaim Indig insider trading
Phreesia, Inc.
Mr. Chaim Indig has made 29 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 3,089 units of PHR stock worth $64,946 on 15 Oct 2024.
The largest trade he's ever made was exercising 123,750 units of PHR stock on 4 May 2021. As of 15 Oct 2024 he still owns at least 1,220,647 units of PHR stock.
Phreesia key executives
Phreesia, Inc. executives and other stock owners filed with the SEC:
- Mr. Chaim Indig (46) Co-Founder, Chief Executive Officer & Director
- Mr. David Linetsky (46) Senior Vice President of Life Sciences
- Mr. Evan Roberts (45) Co-Founder & Chief Operating Officer
- Ms. Allison C. Hoffman (54) Gen. Counsel & Sec.